Arthritis drug may also work for rare eye disease

Arthritis drug may also work for rare eye disease

London, Oct 11 (IANS) A well-known rheumatoid arthritis medication may be effective for treating non-infectious uveitis, a rare eye disease that can lead to loss of vision, new research has found.

Uveitis is the name used for inflammatory conditions of the inner eye, in particular the uvea, which consists of the iris and the ciliary body in the front section and the choroid in the back section. Inflammation can also affect other parts of the eye, such as the retina and the vitreous body.

“We were able to prospectively demonstrate for the very first time that non-infectious uveitis can also be successfully treated with a cortisol-free medication,” said one of the researchers Talin Barisani-Asenbauer from Medical University of Vienna in Austria.

The biologic medication adalimumab has long been used to treat rheumatic diseases and has to be injected subcutaneously every two weeks.

For sufferers, steroid-free means there are fewer side-effects, so that it can be used over a longer period of time.

“That will significantly improve the management of uveitis patients who have only partially responded to corticosteroids, need a corticosteroid sparing therapy or who are unsuitable for treatment with corticosteroids,” Barisani-Asenbauer explained.

The first symptoms of the disease are floaters in the visual field, blurred vision, visual disturbances and photosensitivity.

Potential complications of uveitis are macular oedema (accumulation of fluid in the retina), glaucoma or cataracts, for example. Uveitis can even lead to loss of vision.

The results of the multinational phase-three trial were published in the New England Journal of Medicine.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here